Table 2.
miRNA | Function | Fold Change | Targets |
miR144 | Tumor-suppressive | →772941-fold | Notch-1 |
miR-133b | Tumor-suppressive | →177812-fold | c-MET, FSCN1 |
miR-1 | Tumor-suppressive | →66913-fold | Cyclin D2, CXCR4, SDF1α |
miR-122 | Proapoptotic | →9741-fold | Cyclin B1 |
miR-34c | Tumor-suppressive | →6700-fold | E2F3, Bcl2, c-MET |
miR-200c | Tumor-suppressive | →5077-fold | ZEB1, ZEB2, FN1, MSN |
miR-127 | Tumor-suppressive | →4067-fold | E2F3, Notch-1, Bcl2 |
miR-335 | Tumor-suppressive | →3983-fold | COLA1, SOX4, TNC |
miR-124 | Tumor-suppressive | →1389-fold | ROCK2, EZH2, CDK6 |
miR-181a | Tumor-suppressive | →962-fold | K-ras, Bcl2 |
miR-7 | Tumor-suppressive | →849-fold | Bcl2, EGFR, IGF1R |
miR-215 | Tumor-suppressive | →820-fold | DTL |
miR-15a | Tumor-suppressive | →786-fold | Fgf2, cyclin E2 |
Let-7d | Tumor-suppressive | →4-fold | Twist |
miR-20a | Oncogenic | ↓13587-fold | APP |
miR-21 | Oncogenic | ↓1260-fold | TMP1, Pdcd4, MARCKS |
miR-9 | Oncogenic | ↓173-fold | E-cadherin |
miR-29b | Oncogenic | ↓48-fold | PTEN |
miR-181b | Oncogenic | ↓39-fold | PTEN, TIMP3 |
Effects of PJ on the levels of metastasis-related miRNAs. RNA from PC3 cells treated with L + E + P at 8 µg/ml for 12 hours was submitted to miRNA PCR array analysis. Relative miRNA levels are shown as fold change compared with untreated control.